TVARDI THERAPEUTICS, INC. Deferred Income Tax Expense (Benefit)
TVARDI THERAPEUTICS, INC. (TVRD) reported Deferred Income Tax Expense (Benefit) of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-14
- TVARDI THERAPEUTICS, INC. deferred income tax expense (benefit) for the quarter ending 2026-06-30 was $0.00.
- TVARDI THERAPEUTICS, INC. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was $0.00.
- TVARDI THERAPEUTICS, INC. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00.
- TVARDI THERAPEUTICS, INC. deferred income tax expense (benefit) for the quarter ending 2025-06-30 was $0.00.
- TVARDI THERAPEUTICS, INC. deferred income tax expense (benefit) for fiscal 2018 was $0.00.
- TVARDI THERAPEUTICS, INC. deferred income tax expense (benefit) for fiscal 2017 was $0.00.
- TVARDI THERAPEUTICS, INC. deferred income tax expense (benefit) for fiscal 2016 was $0.00.
- TVARDI THERAPEUTICS, INC. deferred income tax expense (benefit) for fiscal 2015 was $0.00.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $0.00 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | ||
| 2018-12-31 | $0.00 10-K · filed 2019-03-12 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-03-12 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-12 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-15 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-10 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-11 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |